Needs Assessment After Cancer in Patients Treated for Breast Cancer
NCT ID: NCT03902964
Last Updated: 2019-04-04
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
139 participants
OBSERVATIONAL
2018-12-01
2019-02-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Feasibility of Breast Cancer Risk Evaluation in Women From the General Population
NCT02997384
Evaluation of Beauty Care Before Chemotherapy in Women With Breast Cancer
NCT01459003
Fear of Cancer Recurrence (FoR) Trajectory During Radiation Treatment
NCT02599506
5 Years Follow-up With Adjuvant Therapy for Women With Breast Invasive Carcinoma
NCT02791750
Optimizing the Care Pathways of Patients Treated for Operable Breast.
NCT02813317
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Primary objective :
Describe post-cancer supportive care needs, assessed by questionnaire in patients treated for breast cancer after completion of treatment and 2 years later.
Secondary objective :
* Correlation between needs after cancer and the fear of recidivism assessed by the scale of the inventory of fear.
* Compare the need for supportive care between the end of treatment and 2 years after.
* Assess needs after cancer according to the stage of the disease
* Evaluate the needs after cancer according to the treatments received: surgery-radiotherapy versus surgery-chemotherapy-radiotherapy.
* Assess needs after cancer according to age and socio-professional category.
Schedule :
The selected patients then received a letter including an information and non-objection note, the post-cancer needs questionnaire, the Fear Inventory severity subscale questionnaire, and the QLQ-C30 questionnaire. A delay of 1 month was chosen to return the questionnaire with a phone call after 15 days for an analysis of responses in February 2019.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
women treated for breast cancer in 2017 (cohort A)
all patients who completed breast cancer treatment between January 1 and May 31, 2017. Withdrawal of men, metastatic patients from the outset, patients with a history of breast cancer or any other location, selection of 20 patients with breast cancer in situ at random
No interventions assigned to this group
women treated for breast cancer in 2015 (cohorte B)
all patients who completed breast cancer treatment between January 1 and 31 May 2015. Withdrawal of men, metastatic patients from the outset, patients with a history of breast cancer or any other location, selection of 20 patients with breast cancer in situ at random
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
80 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Institut Jean-Godinot
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
stephanie SERVAGI VERNAT, MD
Role: PRINCIPAL_INVESTIGATOR
Institut Jean-Godinot
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Institut Jean Godinot
Reims, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2018-A02191-54
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.